7-(benzyloxy)-2,3,4,5-tetrahydro-1H-3-benzazepine → HCID 59257923, 화합물

반응식

[I:1][C:2]1[C:19]([O:20][CH2:21][C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)=[CH:18][C:5]2[CH2:6][CH2:7][N:8](C(OC(C)(C)C)=O)[CH2:9][CH2:10][C:4]=2[CH:3]=1.C(OC1C=CC2CCNCCC=2C=1)C1C=CC=CC=1>>[I:1][C:2]1[C:19]([O:20][CH2:21][C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)=[CH:18][C:5]2[CH2:6][CH2:7][NH:8][CH2:9][CH2:10][C:4]=2[CH:3]=1

참가 물질

반응물 2

HCID 574376177-(benzyloxy)-2,3,4,5-tetrahydro-1H-3-benzazepine

HCID 592579161,1-Dimethylethyl 7-Iodo-8-[(phenylmethyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate

생성물 1

HCID 59257923HCID 59257923, 화합물

실험 절차

Description D45 (D45) was prepared from 1,1-dimethylethyl 7-iodo-8-[(phenylmethyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate (D44) using the analogous method to that described for Description 2 (D2); MS (ES+) m/e 380 [M+H]+.

출처 및 근거

ORD 기록: ord-7f76732a2487466ab686af009c8082e9
출처 데이터셋: uspto-grants-2012_06
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US08207331B2

반응 노트

불러오는 중…